{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:56:12Z","timestamp":1769838972322,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00066-019-01511-z","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T14:03:32Z","timestamp":1570197812000},"page":"1041-1049","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer\u2014a meta-analysis","Hinzunahme von Chemotherapie zur hyperfraktionierten Strahlentherapie bei fortgeschrittenen malignen Kopf- und Halstumoren \u2013 eine Metaanalyse"],"prefix":"10.1007","volume":"195","author":[{"given":"Jan","family":"Haussmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1lint","family":"Tamaskovics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"B\u00f6lke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freddy-Joel","family":"Djiepmo-Njanang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Kammers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Hautmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pirus","family":"Ghadjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kitti","family":"Maas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas K.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Lammering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried","family":"Budach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Matuschek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"key":"1511_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2407-6-28","volume":"6","author":"W Budach","year":"2006","unstructured":"Budach\u00a0W, Hehr\u00a0T, Budach\u00a0V, Belka\u00a0C, Dietz\u00a0K (2006) A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 6:28","journal-title":"BMC Cancer"},{"key":"1511_CR2","first-page":"S2-72","volume":"24","author":"W Hoffmann","year":"1997","unstructured":"Hoffmann\u00a0W, Rodemann\u00a0HP, Belka\u00a0C et al (1997) Paclitaxel in simultaneous radiochemotherapy of head and neck cancer: preclinical and clinical results. Semin Oncol 24:72\u201377","journal-title":"Semin Oncol"},{"key":"1511_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13014-018-1133-8","volume":"13","author":"C Matuschek","year":"2018","unstructured":"Matuschek\u00a0C, Haussmann\u00a0J, Bolke\u00a0E et al (2018) Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a\u00a0meta-analysis. Radiat Oncol 13:195","journal-title":"Radiat Oncol"},{"key":"1511_CR4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00066-018-1415-y","volume":"195","author":"Y Onbasi","year":"2019","unstructured":"Onbasi\u00a0Y, Lettmaier\u00a0S, Hecht\u00a0M et al (2019) Is there a\u00a0patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a\u00a0previously defined low-risk patient population treated with standard-of-care radiotherapy. Strahlenther Onkol 195:482. \nhttps:\/\/doi.org\/10.1007\/s00066-018-1415-y","journal-title":"Strahlenther Onkol"},{"key":"1511_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00066-018-1293-3","volume":"194","author":"J Schatteman","year":"2018","unstructured":"Schatteman\u00a0J, Van Gestel\u00a0D, Berwouts\u00a0D et al (2018) A feasibility study on adaptive (18)F-FDG-PET-guided radiotherapy for recurrent and second primary head and neck cancer in the previously irradiated territory. Strahlenther Onkol 194:727\u2013736","journal-title":"Strahlenther Onkol"},{"key":"1511_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00066-018-1312-4","volume":"194","author":"M Hreib","year":"2018","unstructured":"Hreib\u00a0M, Krause\u00a0M (2018) No evidence for reduced late toxicity with dose reduction in the elective lymph node region in primary radiochemotherapy of head and neck tumors. Strahlenther Onkol 194:697\u2013698","journal-title":"Strahlenther Onkol"},{"key":"1511_CR7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00066-018-1283-5","volume":"194","author":"M Becker-Schiebe","year":"2018","unstructured":"Becker-Schiebe\u00a0M, Christiansen\u00a0H (2018) Once-a-week versus once-every-three-weeks cisplatin application in combined chemoradiotherapy for locally advanced head and neck cancer? Strahlenther Onkol 194:468\u2013470","journal-title":"Strahlenther Onkol"},{"key":"1511_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijrobp.2013.12.027","volume":"89","author":"JJ Beitler","year":"2014","unstructured":"Beitler\u00a0JJ, Zhang\u00a0Q, Fu\u00a0KK et al (2014) Final results of local-regional control and late toxicity of RTOG 9003: a\u00a0randomized trial of altered fractionation radiation for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 89:13\u201320","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1511_CR9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","volume":"368","author":"J Bourhis","year":"2006","unstructured":"Bourhis\u00a0J, Overgaard\u00a0J, Audry\u00a0H et al (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a\u00a0meta-analysis. Lancet 368:843\u2013854","journal-title":"Lancet"},{"key":"1511_CR10","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","volume":"17","author":"MK Parmar","year":"1998","unstructured":"Parmar\u00a0MK, Torri\u00a0V, Stewart\u00a0L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815\u20132834","journal-title":"Stat Med"},{"key":"1511_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cct.2015.05.009","volume":"45","author":"SA Doi","year":"2015","unstructured":"Doi\u00a0SA, Barendregt\u00a0JJ, Khan\u00a0S, Thalib\u00a0L, Williams\u00a0GM (2015) Advances in the meta-analysis of heterogeneous clinical trials I: the inverse variance heterogeneity model. Contemp Clin Trials 45:130\u2013138","journal-title":"Contemp Clin Trials"},{"key":"1511_CR12","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1200\/JCO.2005.07.010","volume":"23","author":"V Budach","year":"2005","unstructured":"Budach\u00a0V, Stuschke\u00a0M, Budach\u00a0W et al (2005) Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J\u00a0Clin Oncol 23:1125\u20131135","journal-title":"J Clin Oncol"},{"key":"1511_CR13","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ijrobp.2005.09.041","volume":"64","author":"RJ Bensadoun","year":"2006","unstructured":"Bensadoun\u00a0RJ, Benezery\u00a0K, Dassonville\u00a0O et al (2006) French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin\/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC). Int J Radiat Oncol Biol Phys 64:983\u2013994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1511_CR14","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1056\/NEJM199806183382503","volume":"338","author":"DM Brizel","year":"1998","unstructured":"Brizel\u00a0DM, Albers\u00a0ME, Fisher\u00a0SR et\u00a0al (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N\u00a0Engl J Med 338:1798\u20131804","journal-title":"N Engl J Med"},{"key":"1511_CR15","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1200\/JCO.2004.10.076","volume":"22","author":"B Jeremic","year":"2004","unstructured":"Jeremic\u00a0B, Milicic\u00a0B, Dagovic\u00a0A, Vaskovic\u00a0Z, Tadic\u00a0L (2004) Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck. J\u00a0Clin Oncol 22:3540\u20133548","journal-title":"J Clin Oncol"},{"key":"1511_CR16","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.ijrobp.2005.10.039","volume":"64","author":"R Semrau","year":"2006","unstructured":"Semrau\u00a0R, Mueller\u00a0RP, Stuetzer\u00a0H et al (2006) Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5\u2011fluorouracil: updated results of a\u00a0randomized multicentric trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 64:1308\u20131316","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1511_CR17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ijrobp.2014.12.034","volume":"91","author":"V Budach","year":"2015","unstructured":"Budach\u00a0V, Stromberger\u00a0C, Poettgen\u00a0C et al (2015) Hyperfractionated accelerated radiation therapy (HART) of 70.6\u202fGy with concurrent 5\u2011FU\/Mitomycin C is superior to HART of 77.6\u202fGy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial. Int J Radiat Oncol Biol Phys 91:916\u2013924","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1511_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ijrobp.2010.11.067","volume":"82","author":"P Ghadjar","year":"2012","unstructured":"Ghadjar\u00a0P, Simcock\u00a0M, Studer\u00a0G et al (2012) Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a\u00a0randomized phase III trial (SAKK 10\/94). Int J Radiat Oncol Biol Phys 82:524\u2013531","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1511_CR19","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0360-3016(01)01544-9","volume":"50","author":"S Staar","year":"2001","unstructured":"Staar\u00a0S, Rudat\u00a0V, Stuetzer\u00a0H et al (2001) Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy\u2014results of a\u00a0multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 50:1161\u20131171","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1511_CR20","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1200\/JCO.2004.12.193","volume":"22","author":"P Huguenin","year":"2004","unstructured":"Huguenin\u00a0P, Beer\u00a0KT, Allal\u00a0A et\u00a0al (2004) Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J\u00a0Clin Oncol 22:4665\u20134673","journal-title":"J Clin Oncol"},{"key":"1511_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00066-018-1289-z","volume":"194","author":"J Doescher","year":"2018","unstructured":"Doescher\u00a0J, Jeske\u00a0S, Weissinger\u00a0SE et\u00a0al (2018) Polyfunctionality of CD4(+) T lymphocytes is increased after chemoradiotherapy of head and neck squamous cell carcinoma. Strahlenther Onkol 194:392\u2013402","journal-title":"Strahlenther Onkol"},{"key":"1511_CR22","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","volume":"18","author":"B Lacas","year":"2017","unstructured":"Lacas\u00a0B, Bourhis\u00a0J, Overgaard\u00a0J et al (2017) Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncol 18:1221\u20131237","journal-title":"Lancet Oncol"},{"issue":"6","key":"1511_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/annonc\/mdw376","volume":"27","author":"P Blanchard","year":"2016","unstructured":"Blanchard\u00a0P, Landais\u00a0C, Petit\u00a0C et al (2016) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 100 randomized trials and 19,248 patients, on behalf of MACH-NC group. Ann Oncol 27(6):328\u2013350. \nhttps:\/\/doi.org\/10.1093\/annonc\/mdw376","journal-title":"Ann Oncol"},{"key":"1511_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fonc.2019.00122","volume":"9","author":"G Manukian","year":"2019","unstructured":"Manukian\u00a0G, Bar-Ad\u00a0V, Lu\u00a0B, Argiris\u00a0A, Johnson\u00a0JM (2019) Combining radiation and immune checkpoint blockade in the treatment of head and neck squamous cell carcinoma. Front Oncol 9:122","journal-title":"Front Oncol"},{"key":"1511_CR25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner\u00a0JA, Harari\u00a0PM, Giralt\u00a0J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N\u00a0Engl J Med 354:567\u2013578","journal-title":"N Engl J Med"},{"key":"1511_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1385\/MO:23:3:325","volume":"23","author":"T Kuhnt","year":"2006","unstructured":"Kuhnt\u00a0T, Becker\u00a0A, Bloching\u00a0M et al (2006) Phase II trial of a\u00a0simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors. Med Oncol 23:325\u2013333","journal-title":"Med Oncol"},{"key":"1511_CR27","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00066-017-1145-6","volume":"193","author":"T Kuhnt","year":"2017","unstructured":"Kuhnt\u00a0T, Schreiber\u00a0A, Pirnasch\u00a0A et\u00a0al (2017) Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck. Strahlenther Onkol 193:733\u2013741","journal-title":"Strahlenther Onkol"},{"key":"1511_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s12094-013-1118-x","volume":"16","author":"F Arias","year":"2014","unstructured":"Arias\u00a0F, As\u00edn\u00a0G, Uzcanga\u00a0MI et al (2014) Final results of a\u00a0phase II single-institutional trial with hyperfractionated radiation therapy (HFX) and four-weekly continuous cisplatin in locally advanced head and neck carcinoma. Clin Transl Oncol 16:555\u2013560","journal-title":"Clin Transl Oncol"},{"key":"1511_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00066-012-0128-x","volume":"188","author":"J Cvek","year":"2012","unstructured":"Cvek\u00a0J, Kubes\u00a0J, Skacelikova\u00a0E et\u00a0al (2012) Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70\u201375\u202fGy in 5\u00a0weeks for advanced head and neck cancer. Strahlenther Onkol 188:666\u2013670","journal-title":"Strahlenther Onkol"},{"key":"1511_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.radonc.2011.05.036","volume":"100","author":"P Blanchard","year":"2011","unstructured":"Blanchard\u00a0P, Baujat\u00a0B, Holostenco\u00a0V et al (2011) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a\u00a0comprehensive analysis by tumour site. Radiother Oncol 100:33\u201340","journal-title":"Radiother Oncol"},{"key":"1511_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","volume":"21","author":"DJ Adelstein","year":"2003","unstructured":"Adelstein\u00a0DJ, Li\u00a0Y, Adams\u00a0GL et\u00a0al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J\u00a0Clin Oncol 21:92\u201398","journal-title":"J Clin Oncol"},{"key":"1511_CR32","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1093\/jnci\/91.24.2081","volume":"91","author":"G Calais","year":"1999","unstructured":"Calais\u00a0G, Alfonsi\u00a0M, Bardet\u00a0E et al (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J\u00a0Natl Cancer Inst 91:2081\u20132086","journal-title":"J Natl Cancer Inst"},{"key":"1511_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1470-2045(09)70306-7","volume":"11","author":"JS Tobias","year":"2010","unstructured":"Tobias\u00a0JS, Monson\u00a0K, Gupta\u00a0N et al (2010) Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial. Lancet Oncol 11:66\u201374","journal-title":"Lancet Oncol"},{"key":"1511_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0360-3016(95)00078-D","volume":"32","author":"KK Fu","year":"1995","unstructured":"Fu\u00a0KK, Clery\u00a0M, Ang\u00a0KK, Byhardt\u00a0RW, Maor\u00a0MH, Beitler\u00a0JJ (1995) Randomized phase I\/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09. Int J Radiat Oncol Biol Phys 32:589\u2013597","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1511_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0360-3016(87)90258-6","volume":"13","author":"VA Marcial","year":"1987","unstructured":"Marcial\u00a0VA, Pajak\u00a0TF, Chang\u00a0C, Tupchong\u00a0L, Stetz\u00a0J (1987) Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG). Int J Radiat Oncol Biol Phys 13:41\u201347","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1511_CR36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/hed.23661","volume":"37","author":"T Gupta","year":"2015","unstructured":"Gupta\u00a0T, Kannan\u00a0S, Ghosh-Laskar\u00a0S, Agarwal\u00a0JP (2015) Concomitant chemoradiotherapy versus altered fractionation radiotherapy in the radiotherapeutic management of locoregionally advanced head and neck squamous cell carcinoma: An adjusted indirect comparison meta-analysis. Head Neck 37:670\u2013676","journal-title":"Head Neck"},{"key":"1511_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"JP Pignon","year":"2009","unstructured":"Pignon\u00a0JP, le Maitre\u00a0A, Maillard\u00a0E, Bourhis\u00a0J, Group M (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4\u201314","journal-title":"Radiother Oncol"},{"key":"1511_CR38","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1200\/JCO.2000.18.7.1458","volume":"18","author":"B Jeremic","year":"2000","unstructured":"Jeremic\u00a0B, Shibamoto\u00a0Y, Milicic\u00a0B et al (2000) Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a\u00a0prospective randomized trial. J\u00a0Clin Oncol 18:1458\u20131464","journal-title":"J Clin Oncol"},{"key":"1511_CR39","doi-asserted-by":"publisher","first-page":"S194","DOI":"10.1016\/S0167-8140(19)30807-2","volume":"133","author":"R Fietkau","year":"2019","unstructured":"Fietkau\u00a0R, Hecht\u00a0M, Hofner\u00a0B, Iro\u00a0H, Gefeller\u00a0O, R\u00f6del\u00a0C, Hautmann\u00a0M, K\u00f6lbl\u00a0O, Salay\u00a0A, R\u00fcbe\u00a0C, Breinl\u00a0P, Krings\u00a0W, Gripp\u00a0S, Wollenberg\u00a0B, Keerl\u00a0R, Schreck\u00a0U, Siekmeyer\u00a0B, Grabenbauer\u00a0GG Balermpaset P (2019) OC-0387 radiotherapy with paclitaxel\/cisplatin vs. fluorouracil\/cisplatin for head and neck cancer. Radiother Oncol 133:S194","journal-title":"Radiother Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01511-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-019-01511-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01511-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T23:42:29Z","timestamp":1601682149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-019-01511-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,4]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1511"],"URL":"https:\/\/doi.org\/10.1007\/s00066-019-01511-z","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,4]]},"assertion":[{"value":"20 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"J.\u00a0Haussmann, B.\u00a0Tamaskovics, E.\u00a0B\u00f6lke, F.-J.\u00a0Djiepmo-Njanang, K.\u00a0Kammers, S.\u00a0Corradini, M.\u00a0Hautmann, P.\u00a0Ghadjar, K.\u00a0Maas, P.\u00a0Schuler, T.\u00a0Hoffmann, G.\u00a0Lammering, W.\u00a0Budach, and C.\u00a0Matuschek declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"There was no ethics approval necessary because in this meta-analysis, we pulled numbers from the published manuscripts.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}